(NYSE: ALB) Albemarle's forecast annual revenue growth rate of -6.09% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of -4.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Albemarle's revenue in 2024 is $9,617,203,000.On average, 7 Wall Street analysts forecast ALB's revenue for 2024 to be $696,736,840,868, with the lowest ALB revenue forecast at $621,613,863,682, and the highest ALB revenue forecast at $861,918,211,396. On average, 7 Wall Street analysts forecast ALB's revenue for 2025 to be $817,498,218,627, with the lowest ALB revenue forecast at $685,332,435,805, and the highest ALB revenue forecast at $1,136,006,783,922.
In 2026, ALB is forecast to generate $934,409,836,285 in revenue, with the lowest revenue forecast at $778,290,799,390 and the highest revenue forecast at $1,313,311,182,964.